AIFM2 and neoplasm: In conclusion, the mesenchymal profile of OS cells is correlated with ferroptotic sensitivity, suggesting that EMT markers and basal FSP1 levels might be used bona fide to predict the sensitivity of this tumor to ferroptosis, thus indicating ferroptosis as a new valuable anticancer treatment for patients affected by OS.